JOHN CALCAGNINI
Managing Director, Head of Healthcare
Investment Banking
Stout Capital
John Calcagnini is managing director and head of Stout’s Healthcare Investment Banking practice. He has extensive experience with advising healthcare service, medical device and life science companies on mergers, acquisitions, divestitures, joint ventures, restructurings, leveraged buyouts, recapitalizations, and equity and debt financings.
Calcagnini has successfully executed more than 50 transactions in the healthcare industry and had a very strong performance in fiscal 2021 (ended September) and 2022. He recently advised Costa Mesa based SG Homecare on it sale to Sverica Capital; Advent Home Medical on its sale to New Harbor Capital; medical device and industrial product manufacturer RPB Safety on its sale to Italy’s GVS; Rev1 Engineering on its sale to ASAHI INTECC of Japan; and is currently active in representing new clients, who look to Calcagnini for his deep experience and differentiated domain experience and outcomes.
